Skip to main content
TipRanks
Go Ultimate75% OFF

Alembic Pharmaceuticals Limited (APLLTD) Income Statement

2 Followers

Alembic Pharmaceuticals Limited Income Statement

Last quarter (Q2 2027), Alembic Pharmaceuticals Limited's total revenue was ₹26.03B, an increase of 36.30% from the same quarter last year. In Q2, Alembic Pharmaceuticals Limited's net income was ₹3.35B. See Alembic Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementMar 26Mar 25Mar 24Mar 23Mar 22
₹ 73.45B₹ 66.72B₹ 62.29B₹ 56.53B₹ 53.06B
₹ 33.10B₹ 47.91B₹ 44.33B₹ 38.78B₹ 38.08B
₹ 25.10B₹ 20.90B₹ 19.24B₹ 18.97B₹ 19.77B
Depreciation and Amortization₹ 3.19B₹ 2.79B₹ 2.73B₹ 2.75B₹ 2.87B
₹ 11.06B₹ 10.08B₹ 9.33B₹ 7.13B₹ 8.74B
₹ 8.00B₹ 27.02B₹ 25.08B₹ 19.81B₹ 18.31B
₹ -1.06B₹ -19.95B₹ -18.77B₹ -16.26B₹ -12.05B
₹ 6.94B₹ 7.07B₹ 6.32B₹ 3.55B₹ 6.25B
₹ 6.75B₹ 5.83B₹ 6.16B₹ 3.42B₹ 5.21B
Per Share Metrics
Basic EPS₹ 34.33₹ 29.68₹ 31.33₹ 17.40₹ 26.50
Diluted EPS₹ 34.33₹ 29.68₹ 31.33₹ 17.40₹ 26.50
Weighted Average Shares Outstanding196.55M196.56M196.56M196.56M196.56M
Weighted Average Shares Outstanding (Diluted)196.55M196.56M196.56M196.56M196.56M

Currency in INR

Alembic Pharmaceuticals Limited Earnings and Revenue History

030B60B90B0 %8 %16 %24 %EarningsProfit Margin2017201820192020202120222023202420252026RevenueEarningsProfit Margin